Hippocratic AI Raises $141M to Develop AI-Powered Healthcare Assistants | Generative ai use cases in manufacturing | Microsoft generative ai tools list | Generative ai examples in finance | Turtles AI

Hippocratic AI Raises $141M to Develop AI-Powered Healthcare Assistants
Hippocratic AI Raises $141M in Series B to Advance Use of AI in Non-Diagnostic Healthcare Tasks and Address Industry Skills Shortage
Isabella V


Hippocratic AI, an AI startup focused on patient support in healthcare, gets $141 million in Series B with a $1.64 billion valuation, solidifying its position in the industry.

Key points:

  • Innovative focus: developing AI agents for non-diagnostic healthcare tasks.
  • Major investments: raised a total of more than $200 million in less than two years.
  • Strategic partnerships: agreements with 23 health systems and insurers in 2024.
  • Global expansion: new funds earmarked for entry into international markets.


Hippocratic AI secured a significant $141 million Series B funding round led by Kleiner Perkins, reaching a valuation of $1.64 billion. The announcement comes a few months after previous funding rounds: $53 million in the first, backed by General Catalyst and Andreessen Horowitz, and $17 million from the giant Nvidia. This young company, less than two years in business, is rapidly gaining traction with its innovative approach to AI-based health care.

Unlike other companies using generative AI to streamline administrative processes, Hippocratic AI addresses the global shortage of healthcare professionals by developing intelligent assistants capable of handling non-diagnostic but crucial tasks, such as managing preoperative procedures, remotely monitoring patients, and organizing appointments. These tools not only reduce the workload of healthcare professionals but also improve the overall efficiency of the system.

In 2024, Hippocratic AI signed agreements with 23 major health systems and insurance companies, demonstrating the effectiveness of its solutions and solidifying its role as a strategic partner in the industry. With the new funds raised, the company aims to expand its product portfolio internationally, strengthening its presence in key markets and accelerating technology development.

This new round represents another step forward for Hippocratic AI as it continues to innovate in the healthcare industry, offering smart solutions to complex challenges.